Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
暂无分享,去创建一个
John-Arne Røttingen | Sema Mandal | Matthias Egger | Ana Maria Henao-Restrepo | W John Edmunds | Ira M Longini | Miles W Carroll | Anton Camacho | Sven Trelle | Ximena Riveros | Natalie E Dean | Marie Paule Kieny | Sophie Duraffour | M. Egger | N. Dean | W. Edmunds | I. Longini | M. Levine | M. Kieny | R. Grais | A. Camacho | M. Carroll | J. Røttingen | S. Koné | S. Trelle | M. Doumbia | S. Kéïta | A. Henao-Restrepo | B. Draguez | S. Duraffour | G. Enwere | S. Gunther | S. Hossmann | M. K. Kondé | Eeva Kuisma | S. Mandal | G. Norheim | X. Riveros | A. Soumah | A. Vicari | C. Watson | Moussa Doumbia | Godwin Enwere | Stefanie Hossmann | Mandy Kader Kondé | Gunnstein Norheim | Andrea S Vicari | Eeva Kuisma | Stephan Gunther | Myron M Levine | Rebecca Grais | Conall H Watson | Bertrand Draguez | Souleymane Kone | Aboubacar Soumah | Sakoba Kéïta | S. Keïta | M. K. Konde | Stefanie Hossmann | Sakoba Keïta | Ximena Riveros
[1] J. Mascola,et al. Chimpanzee Adenovirus Vector Ebola Vaccine , 2017, The New England journal of medicine.
[2] W. J. Ramsey,et al. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine , 2017, The New England journal of medicine.
[3] E. Cave. Voluntary vaccination: the pandemic effect , 2016, Legal Studies.
[4] M. Altfeld,et al. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe. , 2016, The New England journal of medicine.
[5] John-Arne Røttingen,et al. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola , 2015, BMJ : British Medical Journal.
[6] K. Chu,et al. Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial , 2015, The Lancet.
[7] W. Team. Ebola virus disease among children in West Africa. , 2015 .
[8] Edward Wright,et al. A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA. , 2015, The New England journal of medicine.
[9] Christopher Dye,et al. Ebola vaccine--an urgent international priority. , 2014, The New England journal of medicine.
[10] Mikiko Senga,et al. Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. , 2014, The New England journal of medicine.
[11] H. Feldmann,et al. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. , 2011, The Journal of infectious diseases.
[12] Mario Roederer,et al. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates , 2011, Nature Medicine.
[13] Claudio J. Struchiner,et al. Design and Analysis of Vaccine Studies , 2009 .
[14] P. Grambsch. Survival and Event History Analysis: A Process Point of View by AALEN, O. O., BORGAN, O., and GJESSING, H. K. , 2009 .
[15] Heinz Feldmann,et al. Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus , 2009, Journal of Virology.
[16] D. Torgerson,et al. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals , 2003, BMJ : British Medical Journal.
[17] Allan Donner,et al. Design and Analysis of Cluster Randomization Trials in Health Research , 2001 .
[18] K. Schulz,et al. Subverting randomization in controlled trials. , 1995, JAMA.
[19] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[20] D. Seto,et al. Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report. , 2015, The New England journal of medicine.
[21] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[22] Richard J. Hayes,et al. Cluster randomised trials , 2009 .
[23] F. Fenner. Smallpox and its eradication , 1988 .